CXCL14 regulates cell proliferation, invasion, migration and epithelial-mesenchymal transition of oral squamous cell carcinoma

References

• Kulkarni P, Saxena U. Head and neck cancers, the neglected malignancies: present and future treatment strategies. Expert Opin Ther Targets. 2014;18(4):351–354.
   PubMed Web of Science ®Google Scholar
• Hunter KD, Parkinson EK, Harrison PR. Profiling early head and neck cancer. Nat Rev Cancer. 2005;5(2):127–135.
   PubMed Web of Science ®Google Scholar
• Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer. 2011;11(1):9–22.
   PubMed Web of Science ®Google Scholar
• Mucke T, Mitchell DA, Ritschl LM. Influence of tumor volume on survival in patients with oral squamous cell carcinoma. J Cancer Res Clin Oncol. 2015;141(6):1007–1011.
   PubMed Web of Science ®Google Scholar
• Li Z, Liu J, Li L, et al. Epithelial mesenchymal transition induced by the CXCL9/CXCR3 axis through AKT activation promotes invasion and metastasis in tongue squamous cell carcinoma. Oncol Rep. 2018;39(3):1356–1368.
   PubMed Web of Science ®Google Scholar
• Sleeman MA, Fraser JK, Murison JG, et al. B cell- and monocyte-activating chemokine (BMAC), a novel non-ELR alpha-chemokine. Int Immunol. 2000;12(5):677–689.
   PubMed Web of Science ®Google Scholar
• Kiefer F, Siekmann AF. The role of chemokines and their receptors in angiogenesis. Cell Mol Life Sci. 2011;68(17):2811–2830.
   PubMed Web of Science ®Google Scholar
• Mehrad B, Keane MP, Strieter RM. Chemokines as mediators of angiogenesis. Thromb Haemost. 2007;97(5):755–762.
   PubMed Web of Science ®Google Scholar
• Maehata Y, Ozawa S, Kobayashi K, et al. Reactive oxygen species (ROS) reduce the expression of BRAK/CXCL14 in human head and neck squamous cell carcinoma cells. Free Radic Res. 2010;44(8):913–924.
   PubMed Web of Science ®Google Scholar
• Gu XL, Ou ZL, Lin FJ, et al. Expression of CXCL14 and its anticancer role in breast cancer. Breast Cancer Res Treat. 2012;135(3):725–735.
   PubMed Web of Science ®Google Scholar
• Shellenberger TD, Wang M, Gujrati M, et al. BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells. Cancer Res. 2004;64(22):8262–8270.
   PubMed Web of Science ®Google Scholar
• Ghasri P, Admani S, Petelin A, et al. Treatment of actinic cheilitis using a 1,927-nm thulium fractional laser. Dermatol Surg. 2012;38(3):504–507.
   PubMed Web of Science ®Google Scholar
• Quan J, Elhousiny M, Johnson NW, et al. Transforming growth factor-beta1 treatment of oral cancer induces epithelial-mesenchymal transition and promotes bone invasion via enhanced activity of osteoclasts. Clin Exp Metastasis. 2013;30(5):659–670.
   PubMed Web of Science ®Google Scholar
• Creighton CJ, Chang JC, Rosen JM. Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer. J Mammary Gland Biol Neoplasia. 2010;15(2):253–260.
   PubMed Web of Science ®Google Scholar
• Kang Y, Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell. 2004;118(3):277–279.
   PubMed Web of Science ®Google Scholar
• Straub M, Drecoll E, Pfarr N, et al. CD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity. Oncotarget. 2016;7(11):12024–12034.
   PubMedGoogle Scholar
• Weber M, Wehrhan F, Baran C, et al. PD-L1 expression in tumor tissue and peripheral blood of patients with oral squamous cell carcinoma. Oncotarget. 2017;8(68):112584–112597.
   PubMedGoogle Scholar
• Stasikowska-Kanicka O, Wągrowska-Danilewicz M, Danilewicz M. Immunohistochemical analysis of Foxp3+, CD4+, CD8+ cell infiltrates and PD-L1 in oral squamous cell carcinoma. Pathol Oncol Res. 2018;24(3):497–505.
   PubMed Web of Science ®Google Scholar
• Chang P-H, Hwang-Verslues WW, Chang Y-C, et al. Activation of Robo1 signaling of breast cancer cells by Slit2 from stromal fibroblast restrains tumorigenesis via blocking PI3K/Akt/β-catenin pathway. Cancer Res. 2012;72(18):4652–4661.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Pu Y, Wang L, Wu H, et al. High MMP-21 expression in metastatic lymph nodes predicts unfavorable overall survival for oral squamous cell carcinoma patients with lymphatic metastasis. Oncol Rep. 2014;31(6):2644–2650.
   PubMed Web of Science ®Google Scholar
• Faisal M, Abu Bakar M, Sarwar A, et al. Depth of invasion (DOI) as a predictor of cervical nodal metastasis and local recurrence in early stage squamous cell carcinoma of oral tongue (ESSCOT). PLos ONE. 2018;13(8):e0202632. [cited 2019 Jun 30].
   PubMed Web of Science ®Google Scholar
• Ong HS, Gokavarapu S, Tian Z, et al. PDGFRA mRNA overexpression is associated with regional metastasis and reduced survival in oral squamous cell carcinoma. J Oral Pathol Med. 2018;47(7):652–659.
   PubMed Web of Science ®Google Scholar
• Hata R. A new strategy to find targets for anticancer therapy: chemokine CXCL14/BRAK is a multifunctional tumor suppressor for head and neck squamous cell carcinoma. ISRN Otolaryngol. 2012;2012:1. [cited 2019 May 25];
   Google Scholar
• Ozawa S, Kato Y, Komori R, et al. BRAK/CXCL14 expression suppresses tumor growth in vivo in human oral carcinoma cells. Biochem Biophys Res Commun. 2006;348(2):406–412.
   PubMed Web of Science ®Google Scholar
• Yang H, Pan L, Xu C, et al. Overexpression of tumor suppressor gene ZNF750 inhibits oral squamous cell carcinoma metastasis. Oncol Lett. 2017;14(5):5591–5596.
   PubMed Web of Science ®Google Scholar
• Kim SE, Shin SH, Lee JY, et al. Resveratrol induces mitochondrial apoptosis and inhibits epithelial-mesenchymal transition in oral squamous cell carcinoma cells. Nutr Cancer. 2018;70(1):125–135.
   PubMed Web of Science ®Google Scholar
• Krisanaprakornkit S, Iamaroon A. Epithelial-mesenchymal transition in oral squamous cell carcinoma. ISRN Oncol. 2012;2012:681469. [cited 2019 May 25];
   PubMedGoogle Scholar
• Velcheti V, Schalper KA, Carvajal DE, et al. Programmed death ligand-1 expression in non-small cell lung cancer. Lab Invest. 2014;94(1):107–116.
   PubMed Web of Science ®Google Scholar
• Shi SJ, Wang LJ, Wang GD, et al. B7-H1 expression is associated with poor prognosis in colorectal carcinoma and regulates the proliferation and invasion of HCT116 colorectal cancer cells. PLoS ONE. 2013;8(10):e76012.
   PubMed Web of Science ®Google Scholar
• Zhang P, Liu JZ, Li WL, et al. Lactoferricin B reverses cisplatin resistance in head and neck squamous cell carcinoma cells through targeting PD-L1. Cancer Med. 2018;7(7):3178–3187.
   Web of Science ®Google Scholar
• Cao B, Yang Y, Pan Y, et al. Epigenetic silencing of CXCL14 induced colorectal cancer migration and invasion. Discov Med. 2013;16(88):137–147.
   PubMed Web of Science ®Google Scholar
• Lu JC, Song GH, Tang QL, et al. IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-kappa B signaling. J Clin Invest. 2015;125(5):1839–1856.
   PubMed Web of Science ®Google Scholar